Tuberculosis
Conditions
Interventions
Multi Channel Digital Communication Support
Standard of Care
Sponsors
Ekpeno Mbet Akpanowo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Have a bacteriologically confirmed diagnosis of DR-TB (rifampicin-resistant TB or multidrug-resistant TB). 2. Are newly diagnosed during the study period and not yet enrolled in DR-TB treatment at the time of first contact. 3. Are aged 15 years or older 4. Provide informed consent for participation in the study
Exclusion criteria
Exclusion criteria: 1. Have already been initiated on DR-TB treatment before study enrolment. 2. Have drug-susceptible TB 3. Are unable to provide reliable contact information (phone number) for follow-up through WhatsApp, SMS, or calls. 4. Decline participation or withdraw consent. 5. Clinically diagnosed without bacteriological confirmation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of DRTB patients lost to follow up prior to treatment initiation within 30 days of receipt of a confirmed DR-TB diagnosis by the research team. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Tim, median days, from receipt of confirmed DRTB diagnosis by the research team to initiation of treatment in the intervention and control groups. 2. Proportion of DRTB patients initiating treatment within 7 days and within 14 days of receipt of a confirmed DRTB diagnosis by the research team in the intervention and control groups. 3. Association between patient characteristics and pre-treatment loss to follow-up before treatment initiation within 30 days, Day 0 to 30 inclusive, of receipt of a confirmed DR-TB diagnosis by the research team. | — |
Countries
Nigeria
Contacts
Public ContactEkpeno Akpanowo
Phd Candidate University of Port Harcourt
Outcome results
None listed